Genius Sports Ltd
Change company Symbol lookup
Select an option...
GENI Genius Sports Ltd
SFT Shift Technologies Inc
KMB Kimberly-Clark Corp
NURO NeuroMetrix Inc
OTTW Ottawa Savings Bancorp Inc
HMC Honda Motor Co Ltd
PAVMZ PAVmed Series Z Equity Warrants Exp 30 Apr 2024 *W EXP 04/30/2024
FFBW Ffbw Inc
CIB Bancolombia SA
TARA Protara Therapeutics Inc
Go

Communication Services : Interactive Media & Services | Small Cap Growth
Based in United Kingdom
Company profile

Genius Sports Limited is a provider of technology-led products and services to the sports, sports wagering and sports media industries. Its offerings include Sports Technology and Services; Betting Technology, Content and Services; and Media Technology, Content and Services. It builds and supplies technology and services that allow sports leagues to collect, analyze and monetize their data with added tools to deepen fan engagement. It also offers sports leagues with bespoke monitoring technology and education services to help protect their competitions and athletes from the threats of match fixing and betting-related corruption. It offers official data, outsourced bookmaking, trading/risk management services and live audio-visual game content that is derived from its streaming partnerships with sports leagues. It builds and supplies technology, services and data that enable sportsbooks, sports organizations, and other brands to target, acquire and retain sports fans as their customers.

Closing Price
$2.51
Day's Change
0.26 (11.56%)
Bid
--
Ask
--
B/A Size
--
Day's High
2.53
Day's Low
2.23
Volume
(Below Average)
Volume:
1,321,781

10-day average volume:
1,649,618
1,321,781

SHAREHOLDER ALERT: AFRM AI IBM: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines

1:38 pm ET April 27, 2022 (Accesswire) Print

NEW YORK, NY / ACCESSWIRE / April 27, 2022 / The Law Offices of Vincent Wong announce that class actions have commenced on behalf of certain shareholders in the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff. There will be no obligation or cost to you.

Affirm Holdings, Inc. (NASDAQ:AFRM)

If you suffered a loss, contact us at:https://www.wongesq.com/pslra-1/affirm-holdings-inc-loss-submission-form?prid=26439&wire=1

Lead Plaintiff Deadline: April 29, 2022

Class Period: February 12, 2021 - February 10, 2022



Allegations against AFRM include that: (i) Affirm's "buy now, pay-later" service facilitated excessive consumer debt, regulatory arbitrage, and data harvesting; (ii) the foregoing subjected Affirm to a heightened risk of regulatory scrutiny and enforcement action; (iii) Affirm maintained inadequate disclosure controls and procedures and internal control over financial reporting; (iv) accordingly, Affirm's tweet for its second quarter 2022 financial results contained selected metrics that made it appear that the Company had performed better than it actually did; and (v) as a result, the Company's public statements were materially false and misleading at all relevant times.

C3.ai, Inc.(NYSE:AI)

If you suffered a loss, contact us at:https://www.wongesq.com/pslra-1/c3-ai-inc-loss-submission-form?prid=26439&wire=1

Lead Plaintiff Deadline: May 3, 2022

This lawsuit is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired: (a) C3.ai Class A common stock pursuant and/or traceable to the documents issued in connection with the Company's initial public offering conducted on or about December 9, 2020; and/or (b) C3.ai securities between December 9, 2020 and February 15, 2022, both dates inclusive.



Allegations against AI include that: (i) C3.ai's partnership with Baker Hughes was deteriorating; (ii) C3.ai was employing a flawed accounting methodology to conceal the deterioration of its Baker Hughes partnership; (iii) C3.ai faced challenges in product adoption and significant salesforce turnover; (iv) the Company overstated, inter alia, the extent of its investment in technology, description of its customers, its total addressable market, the pace of its market growth, and the scale of alliances with its major business partners; and (v) as a result, the Company's public statements were materially false and misleading at all relevant times.

International Business Machines Corporation(NYSE:IBM)

If you suffered a loss, contact us at:https://www.wongesq.com/pslra-1/international-business-machines-corporation-loss-submission-form?prid=26439&wire=1

Lead Plaintiff Deadline: June 6, 2022

Class Period: April 4, 2017 - October 20, 2021



Allegations against IBM include that: (i) Strategic Imperatives Revenue and growth, CAMSS and CAMSS Components' revenue and growth, and the Company's Segments' revenue and growth were artificially inflated as a result of the wrongful reclassification of revenues from non-strategic to strategic to make those revenues eligible for treatment as Strategic Imperatives Revenue; (ii) the Company's present success and positive future growth prospects concerning its Strategic Imperative business strategy were being fueled by the wrongful reclassification of revenues from non-strategic to strategic to make those revenues eligible for treatment as Strategic Imperative Revenue and, as a result (iii) the Company misled the market by portraying the Company's Strategic Imperative's financial performance and future prospects more favorable than they actually were as a result of the wrongful reclassification of revenues from non-strategic to strategic to make those revenues eligible for treatment as Strategic Imperatives.

The Law Offices of Vincent Wong, Wednesday, April 27, 2022, Press release picture

To learn more contact Vincent Wong, Esq. either via email vw@wongesq.com or by telephone at 212.425.1140.

Vincent Wong, Esq. is an experienced attorney who has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

Vincent Wong, Esq.

39 East Broadway

Suite 304

New York, NY 10002

Tel. 212.425.1140

Fax. 866.699.3880

E-Mail: vw@wongesq.com

SOURCE: The Law Offices of Vincent Wong





View source version on accesswire.com:

https://www.accesswire.com/699132/SHAREHOLDER-ALERT-AFRM-AI-IBM-The-Law-Offices-of-Vincent-Wong-Reminds-Investors-of-Important-Class-Action-Deadlines



comtex tracking

COMTEX_406338491/2457/2022-04-27T13:38:02

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.